Texas · 89th Legislature (2025) · Bill

HB 3086: Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.

In committee Last action March 20, 2025: Referred to Public Health

Plain-language summary

HB 3086 is a bill introduced in the Texas House on February 20, 2025. According to its official title, it concerns: Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs. Primary sponsor: Tom Oliverson (Republican). Most recent recorded action (March 20, 2025): Referred to Public Health.

Sponsors

Primary sponsor: Tom Oliverson (Republican).